drugset / Trial / NCT01432496

Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy

NCT01432496 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 150 mg produces better postoperative pain control than Saline nebulization after laparoscopic colectomy.

Timeline

Start
2011-09
Primary completion
2012-12
Completion
2012-12

Outcome

Outcome not reported

Stopped (Enrollment): “There was insuficient recruitment in two centers”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 150 mg Other

Indications

No indication recorded.